Author

C. Kempf

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Saraf· 1 shared C. Banks· 1 shared E. Bagu· 1 shared E. Unger· 1 shared G. Hattem· 1 shared J. G. N. Garcia· 1 shared J. MacAusland-Berg· 1 shared J. Mosier· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Saraf

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The impact of intravenous dodecafluoropentane on a murine model of acute lung injury

J. Mosier, S. Sammani, C. Kempf, E. Unger, J. G. N. Garcia

This study evaluates the effect of intravenous dodecafluoropentane on oxygen saturation and bronchoalveolar lavage in a murine model of acute lung injury, showing a significant improvement in oxygenation.

bioRxiv · Aug 17, 2020 · PreprintPharmacology & Toxicology

BRK Phosphorylates SMAD4 for proteasomal degradation and inhibits tumor suppressor FRK to control SNAIL, SLUG and metastatic potential.

S. Miah, C. Banks, Y. Ogunbolude, E. Bagu, J. MacAusland-Berg, A. Saraf, G. Hattem, C. Kempf, M. Sardiu, S. Napper, L. Florens, K. E. Lukong, M. P. Washburn

This study shows BRK phosphorylates SMAD4, leading to its proteasomal degradation and inhibition of the tumor suppressor FRK, which promotes metastasis.

bioRxiv · Dec 7, 2018Cancer Biology